# Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin

> **NCT01422590** · PHASE1 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 26 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Sitagliptin
- **DRUG:** Mitiglinide
- **DRUG:** Sitagliptin, Mitiglinide

## Key facts

- **NCT ID:** NCT01422590
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2011-09-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01422590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01422590, "Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01422590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*